Associating the Change in New COVID-19 Cases to GDP Per Capita in 38 European Countries in the First Wave of the Pandemic
Overview
Authors
Affiliations
COVID-19 has affected all countries globally. We explore associations between the change in new COVID-19 registered cases per million population and various macroeconomic and well-being indicators in 38 European countries over a 2-month period (1st April-31st May 2020). A statistically significant ( = 0.002) negative association was estimated between the change in new COVID-19 cases and GDP per capita, after controlling for key health determinants including public expenditure on health, life expectancy, smoking tobacco and sanitation. The country with the highest GDP per capita in Europe (i.e., Luxemburg) was found to experience the lowest change in new COVID-19 cases within the time period whilst the opposite was found for countries with lower GDP per capita (i.e., Ukraine, Bulgaria, and Romania). The outcomes of this study indicate that, in the first wave of the pandemic in Europe, a country's GDP per capita might be associated with a lower rate of new COVID-19 cases. The study concludes by suggesting that in European regions a country's economic performance should be a critical health priority for policy makers.
Sun Y, Liu W, Zhang G, Shi P Geohealth. 2024; 8(5):e2024GH001025.
PMID: 38784719 PMC: 11114092. DOI: 10.1029/2024GH001025.
How National Culture Influences the Speed of COVID-19 Spread: Three Cross-Cultural Studies.
Huang X, Gupta V, Feng C, Yang F, Zhang L, Zheng J Cross Cult Res. 2024; 57(2-3):193-238.
PMID: 38603334 PMC: 9703026. DOI: 10.1177/10693971221141478.
Social and economic variables explain COVID-19 diffusion in European regions.
Cancedda C, Cappellato A, Maninchedda L, Meacci L, Peracchi S, Salerni C Sci Rep. 2024; 14(1):6142.
PMID: 38480771 PMC: 10937953. DOI: 10.1038/s41598-024-56267-z.
Nesteruk I Front Big Data. 2024; 6:1355080.
PMID: 38269394 PMC: 10806249. DOI: 10.3389/fdata.2023.1355080.
Stroo J, Lepolder M, Murk J, Rijkers G Vaccines (Basel). 2023; 11(9).
PMID: 37766084 PMC: 10535952. DOI: 10.3390/vaccines11091407.